No amplifications of hypoxia-inducible factor-1α gene in invasive breast cancer: A tissue microarray study

Cellular Oncology

Volumn 26, Issue 5-6, 2004, Pages 347-351

  Vleugel, Marije M ^a   Bos, Reinhard ^a   Buerger, Horst ^b   Van Der Groep, Petra ^d   Saramäki, Outi R ^c   Visakorpi, Tapio ^c   Van Der Wall, Elsken ^d   Van Diest, Paul J ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF TAMPERE   (Finland)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Amplification; Breast cancer; FISH; Gene expression; HIF 1 ; Immunohistochemistry

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HIF1A PROTEIN, HUMAN; OXYGEN; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; ANOXIA; BREAST TUMOR; CANCER INVASION; DNA MICROARRAY; FEMALE; GENETICS; MALE; METABOLISM; METHODOLOGY; PATHOLOGY; PROSTATE TUMOR; PROTEIN MICROARRAY;

ANOXIA; BREAST NEOPLASMS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXYGEN; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; TRANSCRIPTION FACTORS;

EID: 21444443309     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. A.G. Anastasiadis, M.A. Ghafar, L. Salomon et al., Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha), J. Cancer Res. Clin. Oncol. 128 (2002), 358-62.
2. R. Bos, P. van der Groep, A.E. Greijer et al., Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma, Cancer 97 (2003), 1573-81.
3. R. Bos, H. Zhong, C.F. Hanrahan et al., Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis, J. Natl. Cancer Inst. 93 (2001), 309-14.
4. R.K. Bruick, Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia, Proc. Natl. Acad. Sci. USA 97 (2000), 9082-7.
5. C.W. Elston and I.O. Ellis, Pathology and breast screening, Histopathology 16 (1990), 109-18.
6. A.L. Harris, Hypoxia - a key regulatory factor in tumour growth, Nat. Rev. Cancer 2 (2002), 38-47.
7. L.E. Huang, Z. Arany, D.M. Livingston et al., Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit, J. Biol. Chem. 271 (1996), 32253-9.
8. E. Hyytinen, T. Visakorpi, A. Kallioniemi et al., Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization, Cytometry 16 (1994), 93-9.
9. B.H. Jiang, E. Rue, G.L. Wang et al., Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1, J. Biol. Chem. 271 (1996), 17771-8.
10. 2-regulated prolyl hydroxylation, Science 292 (2001), 468-72.
11. J. Packeisen, E. Korsching, H. Herbst et al., Demystified . . . tissue microarray technology, Mol. Pathol. 56 (2003), 198-204.
12. O.R. Saramaki, K.J. Savinainen, N.N. Nupponen et al., Amplification of hypoxia-inducible factor 1alpha gene in prostate cancer, Cancer Genet. Cytogenet. 128 (2001), 31-4.
13. M. Schindl, S.F. Schoppmann, H. Samonigg et al., Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer, Clin. Cancer Res. 8 (2002), 1831-7.
14. G.L. Semenza, HIF-1: mediator of physiological and pathophysiological responses to hypoxia, J. Appl. Physiol. 88 (2000), 1474-80.
15. 2 homeostasis by hypoxia-inducible factor 1, Annu. Rev. Cell. Dev. Biol. 15 (1999), 551-78.
16. G.L. Semenza and G.L. Wang, A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation, Mol. Cell. Biol. 12 (1992), 5447-54.
17. D.J. Slamon, W. Godolphin, L.A. Jones et al., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science 244 (1989), 707-12.
18. M.M. Vleugel, A.E. Greijer, A. Shvarts et al., Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancer, (2003) (in press).
19. 2 tension, Proc. Natl. Acad. Sci. USA 92 (1995), 5510-4.
20. U. Woelfle, J. Cloos, G. Sauter et al., Molecular signature associated with bone marrow micrometastasis in human breast cancer, Cancer Res. 63 (2003), 5679-84.
21. A.Y. Yu, M.G. Frid, L.A. Shimoda et al., Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung, Am. J. Physiol. 275 (1998), L818-L826.
22. H. Zhong, A.M. De Marzo, E. Laughner et al., Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases, Cancer Res. 59 (1999), 5830-5.